Back to Journals » Research and Reports in Urology » Call For Papers
Research and Reports in Urology
ISSN: 2253-2447
The following Article Collections/ Thematic Series are currently open for submissions:
The use of AI in Urology and Urologic Oncology
Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The use of AI in Urology and Urologic Oncology", organized by Guest Advisors Michele Marchioni, Daniele Amparore, and Rossella Cicchetti in Research and Reports in Urology.
The rapid advancement of Artificial Intelligence (AI) technologies offers transformative potential in the field of urology. This Article Collection aims to examine the innovative applications and future prospects of AI within urological practice, highlighting its significant impact on diagnostics, treatment planning, and patient care.
The primary objective is to showcase cutting-edge research and practical applications of AI in urology. Key topics of interest include machine learning algorithms for diagnosing various urological disorders, AI-enhanced imaging techniques, robotic surgery applications, and predictive analytics that improve clinical decision-making. We also aim to address the ethical considerations surrounding AI implementation in urology and its potential to change patient outcomes.
The aim is to curate a comprehensive collection of articles focused on "The Use of AI in Urology and Urologic Oncology." This collection is designed to be a valuable resource for publication in prestigious journals specializing in artificial intelligence, urology, and oncology. The subtopics featured within this collection will provide in depth coverage of a wide array of important subjects:
- The application of machine learning algorithms in the diagnosis and identification of various urological disorders. This will include discussions on the latest advancements in algorithmic techniques and their clinical effectiveness in improving diagnostic accuracy.
- Exploration of cutting-edge imaging techniques that have been significantly enhanced through artificial intelligence. These techniques not only improve the quality of imaging but also facilitate more accurate detection and assessment of urological conditions.
- Examination of the role of robotic surgery within urology, highlighting how AI-powered innovations are revolutionizing surgical practices. This will cover both the technological advancements and the clinical benefits associated with robotic-assisted procedures.
- Analysis of predictive analytics tools that leverage AI to support more informed and efficient clinical decision-making processes. These tools have the potential to personalize treatment plans and optimize patient outcomes by predicting disease progression and treatment responses.
- A thorough discussion on the ethical considerations involved in the integration of AI within the field of urology. This will address the potential implications for patient care, data privacy, and the overall impact of AI on healthcare outcomes, ensuring that the adoption of these technologies is both responsible and beneficial.
We encourage submissions from urologists, researchers, data scientists, and healthcare professionals exploring how AI technologies can optimize the management of urological conditions. The Article Collection will serve as a platform to discuss successful case studies, ongoing research, and the challenges associated with integrating AI into clinical practice.
By fostering collaboration and knowledge exchange, this collection intends to illuminate the current landscape of AI in urology and inspire further innovation in the field.
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.
The deadline for submissions is 12 June 2025.
Please submit your manuscript on our website, quoting the promo code JHIPA for a 10% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.
Guest Advisers
Michele Marchioni, Università degli studi G. D.Annunzio
Daniele Amparore, Department of Urology, San Luigi Gonzaga Hospital, Orbassano, Turin - Italy
Rossella Cicchetti, Università degli studi G. D’Annunzio
Focal Therapy in Prostate Cancer: Advances and Clinical Applications
Dove Medical Press is pleased to announce a new Article Collection in Research and Reports in Urology, dedicated to the transformative role of focal therapy in the management of prostate cancer. Since its clinical introduction, focal therapy has revolutionized patient care, offering benefits in preserving urinary and sexual function, minimizing treatment-related morbidity, and enabling targeted cancer control.
Given the importance of focal therapy in managing prostate cancer, Research and Reports in Urology invites submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of these paradigm-shifting therapies.
This collection, edited by Editor-in-Chief Professor Panagiotis J Vlachostergios, is part of the new Game Changer series of Article Collections, spotlighting breakthrough therapies that redefine standards of care and deliver game-changing improvements in patient outcomes.
While the call welcomes manuscripts across the broad spectrum of focal therapy in prostate cancer, the Editors are particularly interested in submissions addressing the following priority areas:
- Patient selection and biomarkers: advances in MRI-guided targeting, genomic profiling, and risk stratification for focal therapy candidacy.
- Energy modalities and technologies: comparative outcomes of HIFU, cryotherapy, laser ablation, and irreversible electroporation.
- Long-term oncologic outcomes: disease-free survival, recurrence patterns, and integration with active surveillance protocols.
- Complications and side effects: Short-term (urinary retention, infection) vs. long-term risks (erectile dysfunction), management strategies for adverse events.
- Technological advancements: AI in treatment planning and imaging interpretation, robotics/real-time imaging integration and nanotechnology, combination therapies (e.g., focal ablation + immunotherapy)
Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.
The deadline for submissions is 1 April 2026.
Please submit your manuscript on our website, quoting the promo code BICXO for a 20% discount on the Article Processing Charge and to indicate that your submission is for consideration in this Article Collection.
Call For Papers
Editor-in-Chief: Dr Panagiotis Vlachostergios
To see where Research and Reports in Urology is indexed online view the Journal Metrics
What is the advantage to you of publishing in Research and Reports in Urology?
- It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
- Unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
- The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Research and Reports in Urology has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
- Many authors have found that our peer reviewer’s comments substantially add to their final papers.
To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.
PubMed Central
Research and Reports in Urology is indexed on PubMed Central (title abbreviation: Res Rep Urol). All published papers in this journal are submitted to PubMed for indexing straight away.
Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.
Yours sincerely
Dr Panagiotis Vlachostergios
Editor-in-Chief
Research and Reports in Urology
Email: Editor-in-Chief
Updated 11 October 2022